Yu Geon Lee Selected Research

veratrole

6/2014

Nonallergenic urushiol derivatives inhibit the oxidation of unilamellar vesicles and of rat plasma induced by various radical generators.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu Geon Lee Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 12/2019
1	Starvation 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 11/2021
1	Neoplasm Metastasis (Metastasis) 02/2021
1	Cholangiocarcinoma 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Adenocarcinoma of Lung 12/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2019
1	Glioblastoma (Glioblastoma Multiforme) 12/2019
1	Melanoma (Melanoma, Malignant) 12/2019
1	Hepatocellular Carcinoma (Hepatoma) 08/2017
1	Contact Dermatitis (Eczema, Contact) 06/2014

Drug/Important Bio-Agent (IBA)

2	urushiolIBA 08/2017 - 06/2014
1	Oxygen (Dioxygen)IBA 01/2022
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2022
1	Phospholipases (Phospholipase)IBA 11/2021
1	CateninsIBA 11/2021
1	Peptide Hydrolases (Proteases)FDA Link 02/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2020
1	AndrogensIBA 01/2020
1	1- (4- ((2- (2- aminopyrimidin- 5- yl)- 7- methyl- 4- morpholinothieno(3,2- d)pyrimidin- 6- yl)methyl)piperazin- 1- yl)- 2- hydroxypropan- 1- oneIBA 01/2020
1	Cisplatin (Platino)FDA LinkGeneric 01/2020
1	Gemcitabine FDA Link 01/2020
1	PeptidomimeticsIBA 12/2019
1	AnionsIBA 12/2019
1	Pharmaceutical PreparationsIBA 12/2019
1	Protein Isoforms (Isoforms)IBA 12/2019
1	Biological ProductsIBA 08/2017
1	AntioxidantsIBA 08/2017
1	LipidsIBA 08/2017
1	veratroleIBA 06/2014
1	catechol (pyrocatechol)IBA 06/2014
1	CarbonIBA 06/2014

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2020
1	Therapeutics 12/2019